Expression of MHC I and NK ligands on human CD133 + glioma cells: possible targets of immunotherapy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neuro-Oncology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s11060-006-9307-x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Targeting cancer stem cells as the most aggressive and tumor-initiating cells

  2026cites this paper
• Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes.

  2022influential citation
• Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells

  2021cites this paper
• Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies

  2021cites this paper
• Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)

  2021cites this paper
• Cancer stem cell–immune cell crosstalk in tumour progression

  2021cites this paper
• The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy

  2021cites this paper
• Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

  2021cites this paper
• Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective

  2021cites this paper
• CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma

  2020cites this paper
• Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion

  2019cites this paper
• Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche

  2019cites this paper
• Cancer stem cells as targets for immunotherapy

  2018cites this paper
• Immune ligands for cytotoxic T Lymphocytes (CTLS) in cancer stem cells (CSCS).

  2018cites this paper
• Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

  2018cites this paper
• Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review)

  2018cites this paper
• Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells

  2018cites this paper
• Sialic acids as cellular markers of immunomodulatory action of dexamethasone on glioma cells of different immunogenicity

  2018cites this paper
• ER–mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem‐like cells

  2017cites this paper
• Immuntherapie gegen Tumorstammzellen bei Plattenepithel­ karzinomen im Kopf­Hals­Bereich Immunotherapy Against Head and Neck Cancer Stem Cells

  2017cites this paper
• Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy

  2017cites this paper
• Targeting Cancer Stem Cells—A Renewed Therapeutic Paradigm

  2017cites this paper
• Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells

  2016cites this paper
• Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes

  2016cites this paper
• Immune phenotypes predict survival in patients with glioblastoma multiforme

  2016cites this paper
• Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties

  2015cites this paper
• Running Head: Craniopharyngioma and Immune Response

  2015cites this paper
• Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

  2015cites this paper
• Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma

  2015influential citation
• Concise Reviews : Targeting Cancer Stem Cells Using Immunologic Approaches

  2015cites this paper
• Immune responses to human cancer stem‐like cells/cancer‐initiating cells

  2015cites this paper
• VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.

  2015cites this paper
• Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

  2015cites this paper
• Immunocompetent murine models for the study of glioblastoma immunotherapy

  2014cites this paper
• Id1 and NF-κB promote the generation of CD133+ and BMI-1+ keratinocytes and the growth of xenograft tumors in mice

  2014cites this paper
• Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro

  2014cites this paper
• Tumor Dormancy, Quiescence, and Senescence, Volume 2

  2014cites this paper
• Therapeutic targeting of malignant glioma.

  2014cites this paper
• Stem Cells and Cancer Stem Cells, Volume 11

  2014cites this paper
• Transcriptional Analysis of Reciprocal Tumor-Microenvironment Interactions in Glioblastoma

  2014cites this paper
• Glioblastoma cancer stem cells--from concept to clinical application.

  2013cites this paper
• Hitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche

  2013cites this paper
• NK cell-based autologous immune enhancement therapy (AIET) for cancer

  2013cites this paper
• Emerging Therapeutic Biomarkers in Endometrial Cancer

  2013cites this paper
• Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo

  2013cites this paper
• Targeting the anti-inflammatory interplay promoting glioblastoma progression with combined natural killer cells and mab9.2.27 against NG2/CSPG4. A novel strategy to reveal glioblastoma to the immune system

  2013cites this paper
• Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells.

  2012cites this paper
• Erratum to “Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours”

  2012cites this paper
• Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours

  2012cites this paper
• Human Glioblastoma Stem‐Like Cells are More Sensitive to Allogeneic NK and T Cell‐Mediated Killing Compared with Serum‐Cultured Glioblastoma Cells

  2012influential citation
• Cancer Therapy : Preclinical Stem-like Tumor-Initiating Cells Isolated from IL 13 R a 2 Expressing Gliomas Are Targeted and Killed by IL 13-Zetakine – Redirected T Cells

  2012cites this paper
• Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine–Redirected T Cells

  2012cites this paper
• Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells

  2011cites this paper
• Natural killer-cell differentiation by myeloid progenitors.

  2011cites this paper
• IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas

  2011cites this paper
• cell differentiation by myeloid progenitors − Natural killer

  2011cites this paper
• Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2.

  2011cites this paper
• The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma

  2011cites this paper
• Equine Herpesvirus Type 1-Mediated Oncolysis of Human Glioblastoma Multiforme Cells

  2011cites this paper
• Immunotherapy targeting colon cancer stem cells.

  2011cites this paper
• Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

  2011cites this paper
• Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

  2010cites this paper
• B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.

  2010cites this paper
• Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy.

  2010cites this paper
• B 7-H 3 and CD 133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis

  2010cites this paper
• Research progression of CD 133 as a marker of cancer stem cells

  2010cites this paper
• NFAT and AP1 are Essential for the Expression of a Glioblastoma Multiforme Related IL-13Ra2 Transcript

  2010cites this paper
• Research progression of CD133 as a marker of cancer stem cells.

  2010cites this paper
• How powerful is CD133 as a cancer stem cell marker in brain tumors?

  2009cites this paper
• Antigen‐Specific T‐Cell Response from Dendritic Cell Vaccination Using Cancer Stem‐Like Cell‐Associated Antigens

  2009cites this paper
• Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.

  2009cites this paper
• Inhibiting glioblastoma multiforme PI 3 K / mTOR signaling without impacting T-cell function Cancer cells

  2009cites this paper
• Targeting CD133 antigen in cancer

  2009cites this paper
• Recurrence of Intracranial Tumors following Adoptive T Cell Therapy Can Be Prevented by Direct and Indirect Killing Aided by High Levels of Tumor Antigen Cross-Presented on Stromal Cells1

  2009cites this paper
• Tumor initiating cells in malignant gliomas: biology and implications for therapy

  2009cites this paper
• NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties1

  2009cites this paper
• Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.

  2009cites this paper
• Stromal Cells Levels of Tumor Antigen Cross-Presented on by Direct and Indirect Killing Aided by High Adoptive T Cell Therapy Can Be Prevented Recurrence of Intracranial Tumors following

  2009cites this paper
• Natural killer cell‐based immunotherapy in cancer: current insights and future prospects

  2009cites this paper
• Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

  2009cites this paper
• Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling

  2007cites this paper
• In Vivo Vaccination With Tumor Cell Lysate Plus CpG Oligodeoxynucleotides Eradicates Murine Glioblastoma

  2007cites this paper
• Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma

  2007cites this paper
• Tumor initiating cells in malignant gliomas

  year unknowncites this paper